These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22271337)

  • 1. [Sacral neuromodulation in urology - development and current status].
    Schwalenberg T; Stolzenburg JU; Kriegel C; Gonsior A
    Aktuelle Urol; 2012 Jan; 43(1):39-48. PubMed ID: 22271337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of permanent electrodes in the peripheral nerve evaluation test (PNE-Test) in comparison to conventional wire electrodes].
    Seif C; Bannowsky A; Wefer B; Naumann VC; van der Horst C; Jünemann KP; Braun PM
    Aktuelle Urol; 2006 Jul; 37(4):277-80. PubMed ID: 16878281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sacral nerve stimulation: Interstim therapy.
    Peeren F; Hoebeke P; Everaert K
    Expert Rev Med Devices; 2005 May; 2(3):253-8. PubMed ID: 16288588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
    Hoda MR; Fornara P
    Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sacral neuromodulation for treatment of lower urinary tract dysfunction.
    Hohenfellner M; Dahms SE; Matzel K; Thüroff JW
    BJU Int; 2000 May; 85 Suppl 3():10-9; discussion 22-3. PubMed ID: 11954192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sacral nerve stimulation for neuromodulation of the lower urinary tract.
    Hubsher CP; Jansen R; Riggs DR; Jackson BJ; Zaslau S
    Can J Urol; 2012 Oct; 19(5):6480-4. PubMed ID: 23040633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral neuromodulation for refractory lower urinary tract dysfunction: results of a nationwide registry in Switzerland.
    Kessler TM; Buchser E; Meyer S; Engeler DS; Al-Khodairy AW; Bersch U; Iselin CE; Roche B; Schmid DM; Schurch B; Zrehen S; Burkhard FC
    Eur Urol; 2007 May; 51(5):1357-63. PubMed ID: 17113216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-operation rates after permanent sacral nerve stimulation for refractory voiding dysfunction in women.
    Blandon RE; Gebhart JB; Lightner DJ; Klingele CJ
    BJU Int; 2008 May; 101(9):1119-23. PubMed ID: 18190624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new minimally invasive procedure for pudendal nerve stimulation to treat neurogenic bladder: description of the method and preliminary data.
    Spinelli M; Malaguti S; Giardiello G; Lazzeri M; Tarantola J; Van Den Hombergh U
    Neurourol Urodyn; 2005; 24(4):305-9. PubMed ID: 15977260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
    Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
    Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral neuromodulation in the older woman.
    McAchran SE; Daneshgari F
    Clin Obstet Gynecol; 2007 Sep; 50(3):735-44. PubMed ID: 17762421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term efficacy of sacral neuromodulation in the management of intractable cases of bladder pain syndrome: 14 years of experience in one centre.
    Gajewski JB; Al-Zahrani AA
    BJU Int; 2011 Apr; 107(8):1258-64. PubMed ID: 20883483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sacral nerve neuromodulation (InterStim). Part I: Review of the InterStim system.
    Rittenmeyer H
    Urol Nurs; 2008 Feb; 28(1):15-20. PubMed ID: 18335692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged percutaneous SNM testing does not cause infection-related explanation.
    Amend B; Bedke J; Khalil M; Stenzl A; Sievert KD
    BJU Int; 2013 Mar; 111(3):485-91. PubMed ID: 22738331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety.
    Spinelli M; Sievert KD
    Eur Urol; 2008 Dec; 54(6):1287-96. PubMed ID: 18336992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged sacral neuromodulation testing using permanent leads: a more reliable patient selection method?
    Kessler TM; Madersbacher H; Kiss G
    Eur Urol; 2005 May; 47(5):660-5. PubMed ID: 15826759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction.
    Aboseif S; Tamaddon K; Chalfin S; Freedman S; Kaptein J
    Urology; 2002 Jul; 60(1):52-6. PubMed ID: 12100921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury.
    Sievert KD; Amend B; Gakis G; Toomey P; Badke A; Kaps HP; Stenzl A
    Ann Neurol; 2010 Jan; 67(1):74-84. PubMed ID: 20186953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuromodulation and neurostimulation in urology].
    Scheepens WA; van Kerrebroeck PE
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1730-4. PubMed ID: 11572172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.